Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Torres

Showing results (1061-1070 of 1,246) with videos related to

Pageof 125
Sort By:
Plants (Basel, Switzerland)|November 9, 2024
Antiviral Potential and Chemical Composition of Wild <i>Baccharis crispa</i> Spreng. Populations (Asteraceae) from Córdoba, Argentina: Perspective on Population VariabilityGiuliana Lingua, Ana Guadalupe Chaves, Juan Javier Aguilar, et al.
Lancet (London, England)|July 5, 2003
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotypeSandro Rossetti, Dominique Chauveau, Vickie Kubly, et al.
Annals of Surgical Oncology|September 10, 2022
Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual DiseaseRaymond S Traweek, Allison N Martin, Nikita F Rajkot, et al.
Clinical Kidney Journal|July 5, 2021
A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney diseaseBonnie L Blazer-Yost, Robert L Bacallao, Bradley J Erickson, et al.
Kidney International|January 2, 2018
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Chengli Shen, Douglas P Landsittel, et al.
Scientific Reports|July 2, 2025
A follow-up study on the novel use of contrast-enhanced susceptibility-weighted imaging for extremity desmoid fibromatosis response assessmentRaul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Plos One|January 18, 2013
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric studyAndreas D Kistler, Andreas L Serra, Justyna Siwy, et al.
Cell|July 16, 2013
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotesLuke A Gilbert, Matthew H Larson, Leonardo Morsut, et al.
Annals of Epidemiology|December 7, 2025
Cardiovascular effects of metformin and testosterone replacement therapy in older men with hormone-related cancers and cancer-free populationOmer Abdelgadir, Salome W Njoroge, Anirudh S Babu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2016
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trialMaría V Irazabal, Kaleab Z Abebe, Kyongtae Ty Bae, et al.
Pageof 125

Showing results (1061-1070 of 1,246) with videos related to

Sort By:
Pageof 125
Plants (Basel, Switzerland)|November 9, 2024
Antiviral Potential and Chemical Composition of Wild <i>Baccharis crispa</i> Spreng. Populations (Asteraceae) from Córdoba, Argentina: Perspective on Population VariabilityGiuliana Lingua, Ana Guadalupe Chaves, Juan Javier Aguilar, et al.
Lancet (London, England)|July 5, 2003
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotypeSandro Rossetti, Dominique Chauveau, Vickie Kubly, et al.
Annals of Surgical Oncology|September 10, 2022
Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual DiseaseRaymond S Traweek, Allison N Martin, Nikita F Rajkot, et al.
Clinical Kidney Journal|July 5, 2021
A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney diseaseBonnie L Blazer-Yost, Robert L Bacallao, Bradley J Erickson, et al.
Kidney International|January 2, 2018
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Chengli Shen, Douglas P Landsittel, et al.
Scientific Reports|July 2, 2025
A follow-up study on the novel use of contrast-enhanced susceptibility-weighted imaging for extremity desmoid fibromatosis response assessmentRaul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Plos One|January 18, 2013
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric studyAndreas D Kistler, Andreas L Serra, Justyna Siwy, et al.
Cell|July 16, 2013
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotesLuke A Gilbert, Matthew H Larson, Leonardo Morsut, et al.
Annals of Epidemiology|December 7, 2025
Cardiovascular effects of metformin and testosterone replacement therapy in older men with hormone-related cancers and cancer-free populationOmer Abdelgadir, Salome W Njoroge, Anirudh S Babu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2016
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trialMaría V Irazabal, Kaleab Z Abebe, Kyongtae Ty Bae, et al.
Pageof 125